Citius Oncology/$CTOR
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Citius Oncology
Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies.The Company centers on achieving a market position by advancing therapies with reduced development and clinical risks, and competitive advantages supported by intellectual property and regulatory exclusivity protection. This includes new formulations of previously approved drugs with substantial existing safety and efficacy data or expanded indications for approved therapies. The company focused on key geographies and stakeholders, majorly on cancer centers and patients.
Ticker
$CTOR
Sector
Primary listing
Employees
-
Headquarters
Citius Oncology Metrics
BasicAdvanced
$98M
-
-$0.31
3.10
-
Price and volume
Market cap
$98M
Beta
3.1
52-week high
$6.19
52-week low
$0.55
Average daily volume
180K
Financial strength
Current ratio
0.831
Quick ratio
0.254
Long term debt to equity
6.506
Total debt to equity
6.506
Interest coverage (TTM)
-84.81%
Profitability
Gross margin (TTM)
79.99%
Net profit margin (TTM)
-599.28%
Operating margin (TTM)
-567.43%
Effective tax rate (TTM)
-4.68%
Management effectiveness
Return on assets (TTM)
-13.96%
Return on equity (TTM)
-47.41%
Valuation
Price to revenue (TTM)
21.74
Price to book
1.61
Price to tangible book (TTM)
1.61
Price to free cash flow (TTM)
-3.728
Free cash flow yield (TTM)
-26.82%
Free cash flow per share (TTM)
-0.298
Growth
Earnings per share change (TTM)
-8.44%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Citius Oncology stock?
Citius Oncology (CTOR) has a market cap of $98M as of February 25, 2026.
What is the P/E ratio for Citius Oncology stock?
The price to earnings (P/E) ratio for Citius Oncology (CTOR) stock is 0 as of February 25, 2026.
Does Citius Oncology stock pay dividends?
No, Citius Oncology (CTOR) stock does not pay dividends to its shareholders as of February 25, 2026.
When is the next Citius Oncology dividend payment date?
Citius Oncology (CTOR) stock does not pay dividends to its shareholders.
What is the beta indicator for Citius Oncology?
Citius Oncology (CTOR) has a beta rating of 3.1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.